PI-RADS version 2.1: one small step for prostate MRI

医学 前列腺 医学物理学 放射科 双雷达 核医学 癌症 内科学 乳腺摄影术 乳腺癌
作者
Tristan Barrett,Rajesh Arora,Andrew B. Rosenkrantz,P L Choyke,Barış Türkbey
出处
期刊:Clinical Radiology [Elsevier]
卷期号:74 (11): 841-852 被引量:110
标识
DOI:10.1016/j.crad.2019.05.019
摘要

Multiparametric (mp) prostate magnetic resonance imaging (MRI) is playing an increasingly prominent role in the diagnostic work-up of patients with suspected prostate cancer. Performing mpMRI before biopsy offers several advantages including biopsy avoidance under certain clinical circumstances and targeting biopsy of suspicious lesions to enable the correct diagnosis. The success of the technique is heavily dependent on high-quality image acquisition, interpretation, and report communication, all areas addressed by previous versions of the Prostate Imaging-Reporting and Data System (PI-RADS) recommendations. Numerous studies have validated the approach, but the widespread adoption of PI-RADS version 2 has also highlighted inconsistencies and limitations, particularly relating to interobserver variability for evaluation of the transition zone. These limitations are addressed in the recently released version 2.1. In this article, we highlight the key changes proposed in PI-RADS v2.1 and explore the background reasoning and evidence for the recommendations. Multiparametric (mp) prostate magnetic resonance imaging (MRI) is playing an increasingly prominent role in the diagnostic work-up of patients with suspected prostate cancer. Performing mpMRI before biopsy offers several advantages including biopsy avoidance under certain clinical circumstances and targeting biopsy of suspicious lesions to enable the correct diagnosis. The success of the technique is heavily dependent on high-quality image acquisition, interpretation, and report communication, all areas addressed by previous versions of the Prostate Imaging-Reporting and Data System (PI-RADS) recommendations. Numerous studies have validated the approach, but the widespread adoption of PI-RADS version 2 has also highlighted inconsistencies and limitations, particularly relating to interobserver variability for evaluation of the transition zone. These limitations are addressed in the recently released version 2.1. In this article, we highlight the key changes proposed in PI-RADS v2.1 and explore the background reasoning and evidence for the recommendations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
量子星尘发布了新的文献求助10
刚刚
1秒前
思源应助默而非问采纳,获得10
1秒前
1秒前
ajsdXZ发布了新的文献求助10
1秒前
一只A茂完成签到 ,获得积分10
2秒前
科研通AI2S应助六月采纳,获得10
2秒前
Haoru应助自由白秋采纳,获得30
2秒前
3秒前
3秒前
3秒前
3秒前
nidie发布了新的文献求助10
3秒前
挖井发布了新的文献求助10
3秒前
所所应助yuanyuan采纳,获得10
5秒前
Rex完成签到,获得积分10
5秒前
黎明锦葵完成签到,获得积分10
5秒前
windking发布了新的文献求助10
5秒前
幸福的含雁应助一一采纳,获得80
6秒前
6秒前
奇迹藤藤完成签到,获得积分10
6秒前
7秒前
7秒前
7秒前
minsu发布了新的文献求助10
7秒前
7秒前
7秒前
公司账号2发布了新的文献求助10
8秒前
彭于晏应助ajsdXZ采纳,获得10
8秒前
8秒前
好心秦完成签到,获得积分10
8秒前
朴实香露发布了新的文献求助10
8秒前
细腻之云发布了新的文献求助10
9秒前
9秒前
咎不可完成签到,获得积分10
10秒前
奇迹藤藤发布了新的文献求助10
10秒前
hif1a发布了新的文献求助10
10秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Terrorism and Power in Russia: The Empire of (In)security and the Remaking of Politics 1000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6045347
求助须知:如何正确求助?哪些是违规求助? 7817036
关于积分的说明 16247944
捐赠科研通 5190880
什么是DOI,文献DOI怎么找? 2777721
邀请新用户注册赠送积分活动 1760771
关于科研通互助平台的介绍 1643963